No improvement in the reporting of clinical trial subgroup effects in high-impact general medical journals

被引:0
作者
Nicole B. Gabler
Naihua Duan
Eli Raneses
Leah Suttner
Michael Ciarametaro
Elizabeth Cooney
Robert W. Dubois
Scott D. Halpern
Richard L. Kravitz
机构
[1] University of Pennsylvania,Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine
[2] Columbia University,Department of Psychiatry and New York Psychiatric Institute
[3] University of Pennsylvania,Department of Biostatistics, Perelman School of Medicine
[4] National Pharmaceutical Council,Department of Medicine, Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine
[5] University of Pennsylvania,Department of Internal Medicine, Division of General Medicine
[6] University of California Davis School of Medicine,undefined
来源
Trials | / 17卷
关键词
Randomized controlled trial; Heterogeneity of treatment effects; Subgroup analysis; Methodology; Multivariable risk index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 126 条
[1]  
Kravitz RL(2004)Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages Milbank Q 82 661-87
[2]  
Duan N(2010)Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal Trials. 11 85-12
[3]  
Braslow J(2007)Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification JAMA 298 1209-7
[4]  
Kent DM(2003)Are some patients likely to benefit from recombinant tissue-type plasminogen activator for acute ischemic stroke even beyond 3 hours from symptom onset? Stroke 34 464-22
[5]  
Rothwell PM(2002)Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned Circulation 105 917-9
[6]  
Ioannidis JP(2006)Moderators of treatment outcomes: clinical, research, and policy importance JAMA 296 1286-30
[7]  
Altman DG(2002)Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems Stat Med 21 2917-86
[8]  
Hayward RA(2005)Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Lancet 365 176-94
[9]  
Kent DM(2001)The revised CONSORT statement for reporting randomized trials: explanation and elaboration Ann Intern Med 134 663-94
[10]  
Hayward RA(2007)Statistics in medicine--reporting of subgroup analyses in clinical trials N Engl J Med 357 2189-9